Central de notícias >
Histórias de destaque
-
-
-
-
-
-
Pedalando pelo mieloma múltiplo
Ler mais
A Janssen nas manchetes
Comunicados à imprensa
Dec 10, 2019
United States
DARZALEX® (Daratumumab) Regimen Shows Significant Increase in Progression-Free Survival in Treatment of Patients with Relapsed/Refractory Multiple Myeloma
Dec 09, 2019
United States
DARZALEX® (Daratumumab) Shows Overall Survival Benefit and Continued Improvement in Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant
Dec 08, 2019
United States
Johnson & Johnson Announces Commitment to Support Republic of Rwanda's Preparedness Against Ebola Outbreak
Dec 07, 2019
United States
IMBRUVICA® (ibrutinib) Combination Therapy Data From Two Studies and Long-Term Integrated Analysis Presented at ASH 2019 Show Efficacy and Safety in First-Line Treatment of Chronic Lymphocytic Leukemia
Tweets
Janssen Global
@JanssenGlobal
-
During last year’s #flu season, there were more than 500,000 influenza- related hospitalizations in the US. Read mo… https://t.co/yX77diNoeG
3 hours 16 min ago

Fechar
Galeria de arte
Temos orgulho em apresentar obras de arte criadas por pessoas afetadas pelas doenças com as quais estamos comprometidos em tratar e prevenir.
Ver a galeria

